Phase I trial of amuvatinib in patients with glioblastoma.
Phase of Trial: Phase I
Latest Information Update: 26 Sep 2012
At a glance
- Drugs Amuvatinib (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 26 Sep 2012 Status changed from planning to discontinued prior to trial initiation.
- 13 Aug 2008 New trial record.